Celmatix Inc. Company Profile

07:59 EDT 23rd April 2018 | BioPortfolio

Celmatix is a next-generation women’s health company transforming reproductive health care through genomics and big data. Founded in 2009 and based in New York City, Celmatix is disrupting how women approach their lifelong fertility journey by empowering them and their physicians with more personalized information. The company’s research-driven products include the Fertilome® test, the world’s first multigene panel test that reveals what a woman’s DNA says about her reproductive health, and Polaris®, a real-time predictive analytics platform in use at leading fertility clinics across the U.S., which helps physicians optimize patient outcomes and improve the patient experience.

News Articles [5 Associated News Articles listed on BioPortfolio]

N.Y. health department OKs Celmatix's reproductive health panel test

The New York State Department of Health approved Celmatix's Fertilome multigene panel test as a laboratory-developed test.  -More- 

Celmatix is Awarded $4.5M to Expand Footprint in New York City

Regional Economic Development Council award from New York State supports further scaling and growth for the next-generation women’s health company Today, Celmatix, a ...

Celmatix Names Lori Batta as Chief Commercial Officer

Seasoned healthcare veteran appointed to oversee company's commercial strategy after year of rapid progress Today, Celmatix, a next-generation women’s health company, announ...

Richard Hofbauer Joins Celmatix to Lead Expanding Operations and Growth

Hofbauer will serve as Chief Operating Officer and interim Chief Financial Officer as company scales to meet high demand Today, Celmatix, a next-generation women’s health co...

The Fertilome Test is the First Multigene Panel Test for Women’s Risk of Reproductive Conditions Approved by the NY State Department of Health

Today, Celmatix, a next-generation women’s health company, announced that the Fertilome® genetic test has received full regulatory approval by the New York State (NYS) Departme...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Celmatix Inc.

Celmatix is a next-generation women’s health company transforming reproductive health care through genomics and big data. Founded in 2009 and based in New York City, Celmatix...


Celmatix, Inc. is a New York City-based biotechnology company targeting the reproductive medicine sector. The company aims to provide molecular diagnostic products and services to patients based on pr...

More Information about "Celmatix Inc." on BioPortfolio

We have published hundreds of Celmatix Inc. news stories on BioPortfolio along with dozens of Celmatix Inc. Clinical Trials and PubMed Articles about Celmatix Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celmatix Inc. Companies in our database. You can also find out about relevant Celmatix Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Fertility is the ability of a couple to conceive, but can related to specifically the man or woman. Various reasons can cause a couple to be infertile, and due to the strong desire of these patients to have <!--LGfEGNT2Lhm-->children, a range of ...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Corporate Database Quicklinks

Searches Linking to this Company Record